Abstract
Recently the claim that there is a lag in the time of onset of antidepressant effects has been questioned. This issue rests on contrasting the time course of ultimate responders versus nonresponders on imipramine and amitriptyline. It is concluded that in 1 week on antidepressants “clinicians were capable of detecting changes in general states between the groups and the specific effects of depressed mood and anxiety and the physical expression of distress” (Katz et al. 1987). To examine this issue, we first used the design in which ultimate responders and ultimate nonresponders to antidepressants were compared at 1 and 2 weeks. Clearly there were statistically significant differences between ultimate responders and nonresponders on drug. However, the same was true on placebo. When the ultimate responders on placebo were contrasted to the ultimate responders on drug at 1 and 2 weeks using the Clinical global Impression (CGI) scale and the Hamilton Depression Rating Scale (HDRS), there was no difference between drug and placebo. This was also true for a subgroup of patients who met the criteria for melancholia. We conclude that, if the effects of nonspecific improvement are partialed out, there is no evidence of a medication effect at 1 and 2 weeks.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quitkin, F., McGrath, P., Stewart, J. et al. Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment?. Neuropsychopharmacol 15, 390–394 (1996). https://doi.org/10.1016/0893-133X(95)00272-F
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/0893-133X(95)00272-F
Keywords
This article is cited by
-
Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients
Psychopharmacology (2015)
-
Association of a functional polymorphism in the adrenomedullin gene (ADM) with response to paroxetine
The Pharmacogenomics Journal (2010)
-
Exercise, Learned Helplessness, and the Stress-Resistant Brain
NeuroMolecular Medicine (2008)